Ott David C.

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Sio Gene Therapies Inc. · on record since Jul 13, 2016
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Glori Energy Inc. · on record since Jun 7, 2024
10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
10% owner at Wayfair Inc. · on record since Nov 24, 2014
10% owner at FIRST DATA CORP · on record since Oct 15, 2015
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at FIGS, Inc. · on record since Jun 7, 2021
10% owner at Ginkgo Bioworks Holdings, Inc. · on record since Sep 23, 2021
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
10% owner at Adaptive Biotechnologies Corp · on record since Jun 26, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at · on record since Jul 12, 2019
Former 10% Owner at · on record since Jul 12, 2019
10% owner at · on record since Apr 28, 2020
10% owner at · on record since Apr 8, 2020
10% owner at · on record since Aug 28, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Dec 17, 2020
10% owner at · on record since Sep 21, 2021
10% owner at · on record since Oct 1, 2021
10% owner at · on record since Jan 13, 2022
10% owner at · on record since Nov 25, 2022
Former 10% Owner at · on record since Jul 12, 2019

Insider trading activity of Ott David C.

Transactions on record: 57; since Feb 8, 2016

Open-market buys: 19; $226.8M

Open-market sells: 10; $525.2M

Companies traded: 13; last filing Jun 18, 2024

Figures computed from official regulatory filings — .

Companies where Ott David C. has traded

10 tx · $500.7M · Jun 18, 2024
2 tx · Feb 28, 2024
4 tx · $70M · Aug 30, 2023
4 tx · $128.7M · Jun 26, 2023
2 tx · $8.5M · Nov 4, 2022
2 tx · Mar 4, 2022
5 tx · $25.3M · Dec 17, 2020
11 tx · $252.6M · Nov 13, 2020
1 tx · $13.1M · Apr 8, 2020
3 tx · $100M · May 23, 2019
1 tx · $25M · Jun 7, 2018
1 tx · $66.4M · Jan 16, 2018
11 tx · Feb 8, 2016

Track record of Ott David C.

Statistical track record

Free account

Open-market buys: 21

Last buy: Aug 28, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Ott David C.

Co-insiders of Ott David C.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
APi Group CorpListing on record	Jun 18, 2024	Sell	-1,912,750	38.15 USD	$73M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-1,912,750	38.15 USD	$73M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-39,032	38.15 USD	$1.5M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-39,032	38.15 USD	$1.5M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	164,016	24.60 USD	$4M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	-81,300	36.90 USD	$3M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	-3,983,739	36.90 USD	$147M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	8,036,862	24.60 USD	$197.7M		SEC
APi Group CorpListing on record	Mar 1, 2024	OtherD (derivative)	-196,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APi Group CorpListing on record	Mar 1, 2024	OtherD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RayzeBio, Inc.Listing unverified	Feb 28, 2024	Other	-4,899,144	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Feb 28, 2024	Other	-1,743,556	—	n/a (No price was disclosed in the filing)		SEC
Inhibrx, Inc.Listing unverified	Aug 30, 2023	BuyD (derivative)	1,038,765	19.35 USD	$20.1M		SEC
Inhibrx, Inc.Listing unverified	Aug 30, 2023	Buy	511,627	19.35 USD	$9.9M	conv 30	SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-5,427,043	9.90 USD	$53.7M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-2,226,195	9.90 USD	$22M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-110,756	9.90 USD	$1.1M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-5,236,006	9.90 USD	$51.8M		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 4, 2022	Buy	279,530	10.08 USD	$2.8M	conv 20	SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 4, 2022	Buy	567,532	10.08 USD	$5.7M	conv 20	SEC
Inhibrx, Inc.Listing unverified	Oct 12, 2022	Buy	333,333	30.00 USD	$10M	conv 32First in 12mo	SEC
Inhibrx, Inc.Listing unverified	Oct 12, 2022	Buy	1,000,000	30.00 USD	$30M	conv 46First in 12mo	SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Mar 4, 2022	OtherD (derivative)	288,000,000	—	n/a (No price was disclosed in the filing)		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Mar 4, 2022	Other	-288,000,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Dec 17, 2020	Other	833,333	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
APi Group CorpListing on record	Jun 18, 2024	Sell	-1,912,750	38.15 USD	$73M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-1,912,750	38.15 USD	$73M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-39,032	38.15 USD	$1.5M		SEC
APi Group CorpListing on record	Jun 18, 2024	Sell	-39,032	38.15 USD	$1.5M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	164,016	24.60 USD	$4M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	-81,300	36.90 USD	$3M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	-3,983,739	36.90 USD	$147M		SEC
APi Group CorpListing on record	Mar 1, 2024	Other	8,036,862	24.60 USD	$197.7M		SEC
APi Group CorpListing on record	Mar 1, 2024	OtherD (derivative)	-196,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APi Group CorpListing on record	Mar 1, 2024	OtherD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RayzeBio, Inc.Listing unverified	Feb 28, 2024	Other	-4,899,144	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Feb 28, 2024	Other	-1,743,556	—	n/a (No price was disclosed in the filing)		SEC
Inhibrx, Inc.Listing unverified	Aug 30, 2023	BuyD (derivative)	1,038,765	19.35 USD	$20.1M		SEC
Inhibrx, Inc.Listing unverified	Aug 30, 2023	Buy	511,627	19.35 USD	$9.9M	conv 30	SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-5,427,043	9.90 USD	$53.7M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-2,226,195	9.90 USD	$22M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-110,756	9.90 USD	$1.1M		SEC
Roivant Sciences Ltd.Listing on record	Jun 26, 2023	Sell	-5,236,006	9.90 USD	$51.8M		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 4, 2022	Buy	279,530	10.08 USD	$2.8M	conv 20	SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 4, 2022	Buy	567,532	10.08 USD	$5.7M	conv 20	SEC
Inhibrx, Inc.Listing unverified	Oct 12, 2022	Buy	333,333	30.00 USD	$10M	conv 32First in 12mo	SEC
Inhibrx, Inc.Listing unverified	Oct 12, 2022	Buy	1,000,000	30.00 USD	$30M	conv 46First in 12mo	SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Mar 4, 2022	OtherD (derivative)	288,000,000	—	n/a (No price was disclosed in the filing)		SEC
Ginkgo Bioworks Holdings, Inc.Listing on record	Mar 4, 2022	Other	-288,000,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Dec 17, 2020	Other	833,333	—	n/a (No price was disclosed in the filing)		SEC